High incidence of malignant pheochromocytoma in a surgical unit. 26 cases out of 100 patients operated from 1971 to 1991
- PMID: 1479148
- DOI: 10.1007/BF03345810
High incidence of malignant pheochromocytoma in a surgical unit. 26 cases out of 100 patients operated from 1971 to 1991
Abstract
In this surgical series of 100 pheochromocytomas (PH), where 91 cases were studied and followed up, the frequency of malignancy appears high (29%) on macroscopic criteria observed at the first operation (25 out 26 cases of malignant PH) or thanks to the occurrence of metastases (1 case out of 26 malignant PH). While some clinical signs are suggestive, there is no excretory profile predictive of malignancy. Isolated or predominant secretion of dopamine is not specific of malignancy event if it occurs more frequently and severely in malignant PH. Bilateral involvement, occurring in the setting of phacomatosis or of multiple endocrine neoplasia (MEN II), or in a sporadic case, is not a predictor for malignancy. Contrarily, extraadrenal involvement is a major feature indicative of malignancy. A CT scan which demonstrates possible locoregional invasion, and a MIGB scan revealing distant localizations raise the suspicion of malignancy. The preferred surgical approach is via a laparotomy, thus allowing the exploration of all possible abdominal chromaffin site and the search for intraabdominal metastases. Intraoperative MIBG scanning checks the completeness of the excision. Flow cytometric DNA ploidy studies have been performed in 25 of our patients. The follow up of benign or malignant PH, after excision "for cure" must be life-long: clinically, biologically and by MIGB scan. Persistence of the disease after surgery or recurrence with unresectable metastases can benefit from MIGB and chemotherapy.
Similar articles
-
Malignant pheochromocytoma: a series of 14 cases observed between 1966 and 1990.J Endocrinol Invest. 1992 Oct;15(9):643-9. doi: 10.1007/BF03345808. J Endocrinol Invest. 1992. PMID: 1479147
-
Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases.J Endocrinol Invest. 1992 Oct;15(9):631-42. doi: 10.1007/BF03345807. J Endocrinol Invest. 1992. PMID: 1479146
-
Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute.Int J Urol. 2007 Mar;14(3):181-5. doi: 10.1111/j.1442-2042.2007.01687.x. Int J Urol. 2007. PMID: 17430251
-
Treatment of malignant pheochromocytoma.Horm Metab Res. 2009 Sep;41(9):687-96. doi: 10.1055/s-0029-1231025. Epub 2009 Aug 11. Horm Metab Res. 2009. PMID: 19672813 Free PMC article. Review.
-
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma.Curr Treat Options Oncol. 2020 Aug 29;21(11):85. doi: 10.1007/s11864-020-00787-z. Curr Treat Options Oncol. 2020. PMID: 32862332 Free PMC article. Review.
Cited by
-
"The" pheochromocytoma: a benign, intra-adrenal, hypertensive, sporadic unilateral tumor. Does it exist?World J Surg. 1994 Jul-Aug;18(4):467-72. doi: 10.1007/BF00353738. World J Surg. 1994. PMID: 7725730
-
Frequency of pheochromocytoma in adrenal incidentalomas and utility of the glucagon test for the diagnosis.J Endocrinol Invest. 1997 Feb;20(2):65-71. doi: 10.1007/BF03347978. J Endocrinol Invest. 1997. PMID: 9125485 Clinical Trial.
-
Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status.Eur J Cancer. 2012 Jul;48(11):1739-49. doi: 10.1016/j.ejca.2011.07.016. Epub 2011 Oct 28. Eur J Cancer. 2012. PMID: 22036874 Free PMC article.
-
Dual loss of rb1 and Trp53 in the adrenal medulla leads to spontaneous pheochromocytoma.Neoplasia. 2010 Mar;12(3):235-43. doi: 10.1593/neo.91646. Neoplasia. 2010. PMID: 20234817 Free PMC article.
-
Predictive characteristics of malignant pheochromocytoma.Korean J Urol. 2011 Apr;52(4):241-6. doi: 10.4111/kju.2011.52.4.241. Epub 2011 Apr 22. Korean J Urol. 2011. PMID: 21556209 Free PMC article.
References
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical